Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 1 , Pages 55-63, March 2009

Development and clinical trial of nano-atropine sulfate dry powder inhaler as a novel organophosphorous poisoning antidote

  • Raisuddin Ali, MPharm

      Affiliations

    • Faculty of Pharmacy, Department of Pharmaceutics, Hamdard University, New Delhi, India
  • ,
  • Gaurav K. Jain, MPharm

      Affiliations

    • Faculty of Pharmacy, Department of Pharmaceutics, Hamdard University, New Delhi, India
  • ,
  • Zeenat Iqbal, PhD

      Affiliations

    • Faculty of Pharmacy, Department of Pharmaceutics, Hamdard University, New Delhi, India
  • ,
  • Sushma Talegaonkar, PhD

      Affiliations

    • Faculty of Pharmacy, Department of Pharmaceutics, Hamdard University, New Delhi, India
  • ,
  • Pragati Pandit, PhD

      Affiliations

    • Cipla Ltd., Mumbai, India
  • ,
  • Sunita Sule, BPharm

      Affiliations

    • Cipla Ltd., Mumbai, India
  • ,
  • Geena Malhotra, BPharm

      Affiliations

    • Cipla Ltd., Mumbai, India
  • ,
  • Roop K. Khar, PhD

      Affiliations

    • Faculty of Pharmacy, Department of Pharmaceutics, Hamdard University, New Delhi, India
  • ,
  • Aseem Bhatnagar, MD

      Affiliations

    • Division of Nuclear Medicine, Institute of Nuclear Medicine and Allied Sciences, New Delhi, India
    • Corresponding Author InformationCorresponding author.
  • ,
  • Farhan J. Ahmad, PhD

      Affiliations

    • Faculty of Pharmacy, Department of Pharmaceutics, Hamdard University, New Delhi, India

Received 17 July 2007; accepted 11 July 2008. published online 17 September 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 No conflict of interest was reported by the authors of this paper.

PII: S1549-9634(08)00094-4

doi:10.1016/j.nano.2008.07.001

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 1 , Pages 55-63, March 2009